Well-being outcomes in therapy: SWLS, FS, and MHC-SF compared

Symptom-reduction measures like the PHQ-9 tell you whether a patient is getting less unwell. They don't tell you whether they're getting more well. For that, therapy outcomes benefit from at least one well-being measure — and the three most defensible short options are the SWLS, the Flourishing Scale, and the MHC-SF.

SWLS — Satisfaction With Life Scale

Five items, one dimension: global cognitive judgment of one's life. The SWLS is the fastest well-being measure that still carries decades of validation. It's insensitive to short-term mood swings, which is a feature — it tracks the stable life-evaluation dimension of well-being, not affect. Use it as a session-1 baseline and a 3- or 6-month follow-up marker.

FS — Flourishing Scale

Eight items covering meaning, engagement, competence, relationships, contribution, optimism and self-worth. Where the SWLS asks "how good is your life?", the FS asks "how well is your life going?" It's the right measure when therapy targets purpose, growth or values-based living (ACT, meaning-centered work). Single total score, easy to feed back to the patient.

MHC-SF — Mental Health Continuum Short Form

Fourteen items across three subscales: emotional, social and psychological well-being. The MHC-SF is the only one of the three that classifies patients as flourishing, moderate, or languishing based on frequency thresholds — a categorical output that pairs naturally with symptom-based diagnosis to give a two-axis picture (Keyes' complete-mental-health model). Use it when the case is complex or when you want a defensible outcome for institutional reporting.

Which to pick

For a lean private-practice battery, pair one symptom measure (PHQ-9 or DASS-21) with the SWLS or FS. For research, complex adult cases, or institutional outcome tracking, the MHC-SF gives more per minute of patient time. Avoid stacking all three — they overlap enough that the marginal information after the first well-being measure is small.

Retest interval

Well-being measures are less reactive than symptom measures. Retesting more often than every 6–8 weeks generates noise that a patient may misread as therapy failure. Set expectations at baseline.